Relapsed Refractory Tumors clinical trials

Explore recruiting relapsed refractory tumors clinical trials.

Recruiting relapsed refractory tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1/2 Dose Determination and Dose Expansion Study of Cobolimab in Combination with Dostarlimab in Pediatric and Young Adult Participants with Newly Diagnosed and Relapsed/Refractory Tumors (POPSTAR)

Spain, France, Germany, Denmark, Italy, Czechia

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Relapsed Refractory Tumors trials by city

Relapsed Refractory Tumors in Toronto Relapsed Refractory Tumors in Vancouver Relapsed Refractory Tumors in Montreal Relapsed Refractory Tumors in Calgary Relapsed Refractory Tumors in Edmonton Relapsed Refractory Tumors in Ottawa Relapsed Refractory Tumors in Winnipeg Relapsed Refractory Tumors in Quebec City Relapsed Refractory Tumors in Hamilton Relapsed Refractory Tumors in Kitchener Relapsed Refractory Tumors in London Relapsed Refractory Tumors in Halifax Relapsed Refractory Tumors in New York Relapsed Refractory Tumors in Los Angeles Relapsed Refractory Tumors in Chicago Relapsed Refractory Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease